26 May 2011 Mymetics Realizes Successful Phase I Study With Its Innovative HIV Vaccine MYM-V101
25 May 2011 The ACTG Immunizes First Subject in Clinical Trial of Profectus BioSciences’ Therapeutic HIV DNA Vaccine
25 May 2011 Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
24 May 2011 ImmunoCellular Therapeutics to Present New Data from Phase I Study of ICT-107 in Glioblastoma Multiforme at ASCO 2011
24 May 2011 Paladin Labs Files New Drug Submission for Oralair(TM)
20 May 2011 Celiac Disease Vaccine Shows Promising Results in Phase I Trial
19 May 2011 Advantagene Announces SPA Agreement With FDA to Launch Phase 3 Trial for Novel Vaccine Aimed at Preventing Prostate Cancer Recurrence
17 May 2011 DBV Demonstrates Ability of VIASKIN to Administer Allergen via Intact Skin by Targeting Dendritic Cells for Safe Treatment of Allergic Disease
10 May 2011 FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection
09 May 2011 Pfizer’s Prevnar 13 Meets All Study Endpoints In Two Pivotal Phase 3 Trials In Adults Aged 50 And Older Presented Today
09 May 2011 Staphylococcus aureus Investigational Vaccine Elicits a Positive Immune Response in Phase 1 Study
09 May 2011 Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
09 May 2011 ImmusanT Reports Positive Results from Nexvax2 Phase 1 Study in Celiac Disease
06 May 2011 KAEL-GemVax: TeloVac Becomes World’s Largest Ever Pancreatic Cancer Vaccine Trial
05 May 2011 ImmunoCellular Therapeutics Announces Updated Long-Term Disease-Free Survival Data from Phase I Study in Glioblastoma
03 May 2011 Isconova strengthens product and patent portfolio
02 May 2011 Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio
27 Apr 2011 Vical Announces Encouraging H1N1 Pandemic Influenza Vaccine Phase 1 Results
25 Apr 2011 Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
21 Apr 2011 Merck and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases
20 Apr 2011 NanoBio Announces Development of Nasal Vaccine for the Prevention of Urinary Tract Infections in Collaboration with the University of Michigan
19 Apr 2011 Adamis Completes Acquisition of a Technology for a Potential Universal Cancer Vaccine
18 Apr 2011 Biotech Synergy Acquires Multi-Epitope NSCLC Cancer Vaccine Phase 2 Positive Assets and Related Patents
18 Apr 2011 Advaxis Lead Drug ADXS11-001 Well-Tolerated in 72 Patients, to Date
18 Apr 2011 Aduro BioTech Licenses GVAX Pancreas from BioSante Pharmaceuticals to Develop a Therapeutic Vaccine in Conjunction with CRS-207 for Pancreatic Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up